CorMedix Inc (NASDAQ: CRMD) on Friday, soared 4.57% from the previous trading day, before settling in for the closing price of $12.47. Within the past 52 weeks, CRMD’s price has moved between $2.57 and $12.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -47.11% over the past five years. The company achieved an average annual earnings per share of 31.21%. With a float of $56.86 million, this company’s outstanding shares have now reached $57.76 million.
Let’s look at the performance matrix of the company that is accounted for 82 employees. In terms of profitability, gross margin is -29.14%, operating margin of -5236.86%, and the pretax margin is -4909.87%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CorMedix Inc is 1.56%, while institutional ownership is 29.58%. The most recent insider transaction that took place on Mar 13 ’24, was worth 50,718. In this transaction Chief Executive Officer of this company bought 13,561 shares at a rate of $3.74, taking the stock ownership to the 352,839 shares. Before that another transaction happened on Dec 14 ’23, when Company’s Director bought 3,000 for $3.45, making the entire transaction worth $10,350. This insider now owns 12,250 shares in total.
CorMedix Inc (CRMD) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.17 earnings per share (EPS) for the period topping the consensus outlook (set at -0.21) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.21% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
CorMedix Inc (CRMD) is currently performing well based on its current performance indicators. A quick ratio of 4.43 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 929.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach 0.11 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
CorMedix Inc (NASDAQ: CRMD) saw its 5-day average volume 1.76 million, a positive change from its year-to-date volume of 0.66 million. As of the previous 9 days, the stock’s Stochastic %D was 92.23%. Additionally, its Average True Range was 0.58.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 95.45%, which indicates a significant increase from 89.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.75% in the past 14 days, which was lower than the 70.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.91, while its 200-day Moving Average is $5.24. Nevertheless, the first resistance level for the watch stands at $13.56 in the near term. At $14.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $14.67. If the price goes on to break the first support level at $12.45, it is likely to go to the next support level at $11.86. The third support level lies at $11.34 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
Market capitalization of the company is 753.19 million based on 54,959K outstanding shares. Right now, sales total 0 K and income totals -46,340 K. The company made 810 K in profit during its latest quarter, and -14,150 K in sales during its previous quarter.
